10207 Results

People

  1. Gonen
    Gonen
  2. Vickers
    Vickers
  3. Panageas
    Panageas
  4. Patil
    Patil
  5. Schultz
    Schultz
  6. Giralt
    Giralt
  7. Zhang
    Zhang
  8. Jarnagin
    Jarnagin
  9. Heller
    Heller
  10. D'Angelica
    D'Angelica

Groups

  1. Epidemiology and Biostatistics (10207)
  2. Biostatistics Service (6564)
  3. Department of Medicine (4907)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3597)
  7. Solid Tumor Oncology Division (3294)
  8. GSK Faculty (2807)
  9. Center for Pancreatic Cancer Research (2495)
  10. Health Outcomes Research Group (2069)
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6429)
  2. Meeting Abstract (3245)
  3. Editorial (116)
  4. Review (93)
  5. Research Letter (80)
  6. Correspondence (77)
  7. Conference Paper (54)
  8. Miscellaneous (52)
  9. Book Section (43)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Epidemiology and Biostatistics (10207)
  2. Biostatistics Service (6564)
  3. Department of Medicine (4907)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3597)

More Groups

People
  1. Mithat Gonen (1028)
  2. Andrew Vickers (880)
  3. Sean Devlin (601)
  4. Katherine Panageas (512)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (486)

More People

Years
  1. 2025 (209)
  2. 2024 (622)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1374)
  2. Blood (534)
  3. Annals of Surgical Oncology (462)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (258)
  6. Clinical Cancer Research (250)

More Publications

Publishers
  1. American Society of Clinical Oncology (1487)
  2. Elsevier Inc. (1206)
  3. Springer (925)
  4. American Association for Cancer Research (761)
  5. Elsevier Science, Inc. (685)
  6. American Society of Hematology (601)

More Publishers

Results (10207)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IVAC +/- R for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A. C.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Single cell profiling reveals unique CXCL13 positive T cell subsets in the tumor microenvironment of lymphocyte rich classic Hodgkin lymphoma
    Meeting Abstract

    Aoki, T.; Chong, L. C.; Takata, K.; Milne, K.; Chavez, E.; Miyata-Takata, T.; Ben-Neriah, S.; Unrau, D.; Telenius, A.; Boyle, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer
    Journal Article

    Kuntz, K. M.; Popp, J.; Beck, J. R.; Zauber, A. G.; Weinberg, D. S.
    BMJ Open Gastroenterology (2020)

    Fulltext@MSK | Save
  • Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
    Journal Article

    Bailey, M. H.; Meyerson, W. U.; Dursi, L. J.; Wang, L. B.; Dong, G.; Liang, W. W.; Weerasinghe, A.; Li, S.; Li, Y.; Kelso, S.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Deep direct likelihood knockoffs
    Conference Paper

    Sudarshan, M.; Tansey, W.; Ranganath, R.
    Neural Information Processing Systems Foundation (2020)

    Fulltext@MSK | Save
  • Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk
    Journal Article

    Ghoneim, D. H.; Zhu, J.; Zheng, W.; Long, J.; Murff, H. J.; Ye, F.; Setiawan, V. W.; Wilkens, L. R.; Khankari, N. K.; Haycock, P.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Opioid safety among high-risk cancer survivors
    Meeting Abstract

    Salz, T.; Mishra, A. A.; Gennarelli, R. L.; Lipitz-Snyderman, A.; Boudreau, D.; Moryl, N.; Tringale, K. R.; Korenstein, D.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Chronic opioid therapy among a high-risk cancer survivor population
    Meeting Abstract

    Salz, T.; Lavery, J. A.; Lipitz-Snyderman, A.; Boudreau, D.; Moryl, N.; Gillespie, E. F.; Korenstein, D.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save